ReShape Lifesciences, Inc. (HIND) at a glance

ReShape Lifesciences, Inc. (HIND) is a micro-cap Healthcare company. It trades at $2.21, with a 68.4% profit margin and revenue decline of 46%. It does not pay a dividend. Vestovix scores it 42/100 overall. Its strongest dimension is Value (68/100) and its weakest is Growth (11/100).

Price
$2.21
Market cap
$15.7M
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$1.75 to $18.60
Vestovix Score42/ 100How this works
Value
68
Growth
11
Income
40
Safety
66
Momentum
14

Other Healthcare stocks

See all